Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro

Suganthini Krishnan Natesan, Pranatharthi H. Chandrasekar, George J. Alangaden, Elias K. Manavathu

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Statins (anticholesterol drugs) inhibit HMG-CoA reductase, which is a key rate-limiting enzyme in the synthesis of sterols in fungi. We therefore investigated the in vitro inhibitory activity of various statins against Aspergillus fumigatus alone and in combination with antifungal drugs. Fresh conidial suspensions from 10 clinical isolates of A. fumigatus were obtained. The MIC and minimum fungicidal concentration (MFC) were determined by the Clinical and Laboratory Standards Institute M-38A protocol and the fungicidal activity by time-kill study. Fluvastatin (FST) showed good activity (MIC, 2 mg/L; MFC, 4 mg/L) against A. fumigatus; other statins had no activity (MIC ≥256 mg/L). FST enhanced the activity of caspofungin (CFG) against A. fumigatus; subinhibitory concentrations of FST in combination with CFG showed >99.9% killing of A. fumigatus conidia, whereas either drug alone showed poor activity at subinhibitory concentrations. FST potentiated the antifungal activity of CFG but displayed no specific interaction with voriconazole or amphotericin B.

Original languageEnglish (US)
Pages (from-to)369-373
Number of pages5
JournalDiagnostic Microbiology and Infectious Disease
Volume60
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

fluvastatin
caspofungin
Aspergillus fumigatus
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pharmaceutical Preparations
Hydroxymethylglutaryl CoA Reductases
Fungal Spores
Amphotericin B
Sterols
Suspensions
Fungi
In Vitro Techniques

Keywords

  • Amphotericin B
  • Aspergillus fumigatus
  • Caspofungin
  • Fluvastatin
  • Fungicidal
  • Interaction
  • Kill-curve
  • Voriconazole

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Virology
  • Parasitology
  • Microbiology
  • Immunology
  • Applied Microbiology and Biotechnology

Cite this

Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro. / Natesan, Suganthini Krishnan; Chandrasekar, Pranatharthi H.; Alangaden, George J.; Manavathu, Elias K.

In: Diagnostic Microbiology and Infectious Disease, Vol. 60, No. 4, 01.04.2008, p. 369-373.

Research output: Contribution to journalArticle

Natesan, Suganthini Krishnan ; Chandrasekar, Pranatharthi H. ; Alangaden, George J. ; Manavathu, Elias K. / Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro. In: Diagnostic Microbiology and Infectious Disease. 2008 ; Vol. 60, No. 4. pp. 369-373.
@article{f8594048cda849c690c051e01289240d,
title = "Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro",
abstract = "Statins (anticholesterol drugs) inhibit HMG-CoA reductase, which is a key rate-limiting enzyme in the synthesis of sterols in fungi. We therefore investigated the in vitro inhibitory activity of various statins against Aspergillus fumigatus alone and in combination with antifungal drugs. Fresh conidial suspensions from 10 clinical isolates of A. fumigatus were obtained. The MIC and minimum fungicidal concentration (MFC) were determined by the Clinical and Laboratory Standards Institute M-38A protocol and the fungicidal activity by time-kill study. Fluvastatin (FST) showed good activity (MIC, 2 mg/L; MFC, 4 mg/L) against A. fumigatus; other statins had no activity (MIC ≥256 mg/L). FST enhanced the activity of caspofungin (CFG) against A. fumigatus; subinhibitory concentrations of FST in combination with CFG showed >99.9{\%} killing of A. fumigatus conidia, whereas either drug alone showed poor activity at subinhibitory concentrations. FST potentiated the antifungal activity of CFG but displayed no specific interaction with voriconazole or amphotericin B.",
keywords = "Amphotericin B, Aspergillus fumigatus, Caspofungin, Fluvastatin, Fungicidal, Interaction, Kill-curve, Voriconazole",
author = "Natesan, {Suganthini Krishnan} and Chandrasekar, {Pranatharthi H.} and Alangaden, {George J.} and Manavathu, {Elias K.}",
year = "2008",
month = "4",
day = "1",
doi = "10.1016/j.diagmicrobio.2007.10.015",
language = "English (US)",
volume = "60",
pages = "369--373",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro

AU - Natesan, Suganthini Krishnan

AU - Chandrasekar, Pranatharthi H.

AU - Alangaden, George J.

AU - Manavathu, Elias K.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Statins (anticholesterol drugs) inhibit HMG-CoA reductase, which is a key rate-limiting enzyme in the synthesis of sterols in fungi. We therefore investigated the in vitro inhibitory activity of various statins against Aspergillus fumigatus alone and in combination with antifungal drugs. Fresh conidial suspensions from 10 clinical isolates of A. fumigatus were obtained. The MIC and minimum fungicidal concentration (MFC) were determined by the Clinical and Laboratory Standards Institute M-38A protocol and the fungicidal activity by time-kill study. Fluvastatin (FST) showed good activity (MIC, 2 mg/L; MFC, 4 mg/L) against A. fumigatus; other statins had no activity (MIC ≥256 mg/L). FST enhanced the activity of caspofungin (CFG) against A. fumigatus; subinhibitory concentrations of FST in combination with CFG showed >99.9% killing of A. fumigatus conidia, whereas either drug alone showed poor activity at subinhibitory concentrations. FST potentiated the antifungal activity of CFG but displayed no specific interaction with voriconazole or amphotericin B.

AB - Statins (anticholesterol drugs) inhibit HMG-CoA reductase, which is a key rate-limiting enzyme in the synthesis of sterols in fungi. We therefore investigated the in vitro inhibitory activity of various statins against Aspergillus fumigatus alone and in combination with antifungal drugs. Fresh conidial suspensions from 10 clinical isolates of A. fumigatus were obtained. The MIC and minimum fungicidal concentration (MFC) were determined by the Clinical and Laboratory Standards Institute M-38A protocol and the fungicidal activity by time-kill study. Fluvastatin (FST) showed good activity (MIC, 2 mg/L; MFC, 4 mg/L) against A. fumigatus; other statins had no activity (MIC ≥256 mg/L). FST enhanced the activity of caspofungin (CFG) against A. fumigatus; subinhibitory concentrations of FST in combination with CFG showed >99.9% killing of A. fumigatus conidia, whereas either drug alone showed poor activity at subinhibitory concentrations. FST potentiated the antifungal activity of CFG but displayed no specific interaction with voriconazole or amphotericin B.

KW - Amphotericin B

KW - Aspergillus fumigatus

KW - Caspofungin

KW - Fluvastatin

KW - Fungicidal

KW - Interaction

KW - Kill-curve

KW - Voriconazole

UR - http://www.scopus.com/inward/record.url?scp=40749083534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749083534&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2007.10.015

DO - 10.1016/j.diagmicrobio.2007.10.015

M3 - Article

VL - 60

SP - 369

EP - 373

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 4

ER -